
Dr. Samir Nusair, MD ๐ฎ๐ฑ
3.2K posts

Dr. Samir Nusair, MD ๐ฎ๐ฑ
@SamirNus
Respiratory Physician: tweets on #PulmonaryFibrosis #Sarcoidosis #COPD; focus #RespiratoryPhysiology & #Exercise #Physiology ืืจ' ืกืืืจ ื ืกืืืจ






ืืฆืืจืคื ืื ืืืคื ืืฉืงืืขืื ืฉืืฉืงืืขื ืืืืืื ื ืฉืงืืื ืืจืคืืืช ืืืืจ! ืฆืคื ืืคืจืืค' ืืืืช ืฉื ืขืจ, ืื ืืืช ืฉืืจืืชื ืืื ืฉื ืืืื ืช ืืฉืจืื ืืืื ืืื ืืืื ืฉืื ื ืืฆืืช ืืืืขืื ืืืืืขืฆืช ืฉื ืจื ืกื ืืืืืง, ืืกืคืจืช ืขื ืืฆืืจื ืืืืืจ ืืื ืืช ืื ืืขื ืืคืชืจืื ืืืืฉื ื ืฉืืืืืื ืืืืจื! ืื ืืคืจืืื ืืื ืืืฆืืจืฃ ืืงืืฉืืจ >>








A new preferential (selective) Phosphodiesterase 4 inhibitor with antiinflammatory and antifibrotic properties slows FVC decrease in IPF during 12week therapy, an effect evident even under background antifibrotic therapy. #pulmonaryfibrosis #ATS2022 nejm.org/doi/full/10.10โฆ











